DOI: 10.1055/s-00000077

Seminars in Thrombosis and Hemostasis

Issue 05 · Volume 27 · 2001 DOI: 10.1055/s-002-1229

  • 437
    Naggi, Annamaria; Torri, Giangiacomo; Casu, Benito; Oreste, Pasqua; Zoppetti, Giorgio; Li, Jin-Ping; Lindahl, Ulf:

    Toward a Biotechnological Heparin through Combined Chemical and Enzymatic Modification of the Escherichia coli K5 Polysaccharide

  • 445
    Baumann, Hanno:

    The Role of Regioselectively Sulfated and Acetylated Polysaccharide Coatings of Biomaterials for Reducing Platelet and Plasma Protein Adhesion

  • 465
    Sturiale, Luisa; Naggi, Annamaria; Torri, Giangiacomo:

    MALDI Mass Spectrometry as a Tool for Characterizing Glycosaminoglycan Oligosaccharides and their Interaction with Proteins

  • 473
    Guerrini, Marco; Bisio, Antonella; Torri, Giangiacomo:

    Combined Quantitative 1H and 13C Nuclear Magnetic Resonance Spectroscopy for Characterization of Heparin Preparations

  • 483
    Sissi, Claudia; Naggi, Annamaria; Torri, Giangiacomo; Palumbo, Manlio:

    Effects of Sulfation on Antithrombin-Thrombin/Factor Xa Interactions in Semisynthetic Low Molecular Weight Heparins

  • 489
    Bretschneider, Ellen; Schrör, Karsten:

    Cellular Effects of Factor Xa on Vascular Smooth Muscle Cells-Inhibition by Heparins?

  • 495
    Kaiser, Phoebe; Harenberg, Job; Hoppensteadt, Debra; Walenga, Jeanine M.; Huhle, Günther; Giese, Christina; Prechel, Margaret; Fareed, Jawed:

    Effects of a Heparin-Binding Protein on Blood Coagulation and Platelet Function

  • 503
    Alban, Susanne:

    Molecular Weight-Dependent Influence of Heparin on the Form of Tissue Factor Pathway Inhibitor Circulating in Plasma

  • 513
    Harenberg, Job; Huisman, Menno V.; Tolle, Alexander R.; Breddin, H. Klaus; Kirchmaier, Claus M.:

    Reduction in Thrombus Extension and Clinical End Points in Patients after Initial Treatment for Deep Vein Thrombosis with the Fixed-Dose Body Weight-Independent Low Molecular Weight Heparin Certoparin

  • 519
    Boneu, Bernard; de Moerloose, Philippe:

    How and When to Monitor a Patient Treated with Low Molecular Weight Heparin

  • 523
    Markwardt, Fritz:

    Development of Direct Thrombin Inhibitors in Comparison with Glycosaminoglycans

  • 531
    Zokai, Kaweh; Piazolo, Lukas; Harenberg, Job:

    Effect of Thrombin Inhibitors and a Glycoprotein IIb/IIIa Receptor Antagonist in an Ex Vivo Human Experimental Thrombosis Model

  • 537
    Nowak, Götz:

    Clinical Monitoring of Hirudin and Direct Thrombin Inhibitors

  • 543
    Prisco, Domenico; Falciani, Michela; Antonucci, Emilia; Gensini, Gian Franco:

    Hirudins for Prophylaxis and Treatment of Venous Thromboembolism

  • 551
    Kemkes-Matthes, Bettina; Matthes, Karl J.:

    Protein Z